Legal aspects of fertility preservation in people with reproductive system cancers

The paper analyzes the assisted reproductive technology legislation, in accordance with which malignant neoplasms at any site are contraindications to the use of the basic assisted reproductive technology program. Nonetheless, numerous gynecological oncology studies prove the efficiency of organ-sparing treatments used to preserve reproductive function in young female patients. There is evidence for the need for the legislative consolidation of a possibility to use assisted reproductive technology techniques for the treatment of infertility in people with malignant tumors, provided that there is a positive decision of the Medical Commission chaired by an oncologist/gynecologist, as well as voluntary informed consent from the patient herself.